Kombineret 48 ugers mediantid til behandlingssvigt for begge undersøgelser var 115 dage i APTIVUS/ ritonavir- gruppen og 0 dage i komparatorgruppen (intet behandlingsrespons var tillagt til dag 0).
Combined 48-week median time to treatment failure for both studies was 115 days in the APTIVUS/ ritonavir arm and 0 days in the comparator arm (no treatment response was imputed to day 0).